These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Platelet function in cardiopulmonary bypass and artificial organs. Addonizio VP Hematol Oncol Clin North Am; 1990 Feb; 4(1):145-55. PubMed ID: 2179210 [TBL] [Abstract][Full Text] [Related]
4. Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator. Addonizio VP; Strauss JF; Colman RW; Edmunds LH J Thorac Cardiovasc Surg; 1979 Jan; 77(1):119-26. PubMed ID: 102876 [TBL] [Abstract][Full Text] [Related]
5. Blood platelets and extracorporeal circulation; kinetic studies on dogs on cardiopulmonary bypass. de Leval MR; Hill JD; Mielke CH; Macur F; Gerbode F J Thorac Cardiovasc Surg; 1975 Jan; 69(1):144-51. PubMed ID: 1110575 [TBL] [Abstract][Full Text] [Related]
6. Human albumin in extracorporeal prime: effect on platelet function and bleeding. Kamra C; Beney A Perfusion; 2013 Nov; 28(6):536-40. PubMed ID: 23771563 [TBL] [Abstract][Full Text] [Related]
7. Function of human platelets during extracorporeal circulation. Hennessy VL; Hicks RE; Niewiarowski S; Edmunds LH; Colman RW Am J Physiol; 1977 Jun; 232(6):H622-8. PubMed ID: 18017 [TBL] [Abstract][Full Text] [Related]
9. Effect of nitric oxide gas on platelets during open heart operations. Mellgren K; Mellgren G; Lundin S; Wennmalm A; Wadenvik H Ann Thorac Surg; 1998 May; 65(5):1335-41. PubMed ID: 9594863 [TBL] [Abstract][Full Text] [Related]
12. Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulation. Addonizio VP; Macarak J; Nicolaou KC; Edmunds LH; Colman RW Blood; 1979 Jun; 53(6):1033-42. PubMed ID: 375998 [No Abstract] [Full Text] [Related]
13. Preservation of platelets during extracorporeal circulation with prostaglandin E1. Addonizio VP; Macarak EJ; Niewiarowski S; Colman RW; Edmunds LH Trans Am Soc Artif Intern Organs; 1977; 23():639-45. PubMed ID: 910394 [No Abstract] [Full Text] [Related]
14. The effect of nitric oxide on platelets when delivered to the cardiopulmonary bypass circuit. Lowson SM; Hassan HM; Rich GF Anesth Analg; 1999 Dec; 89(6):1360-5. PubMed ID: 10589608 [TBL] [Abstract][Full Text] [Related]
15. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue. Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591 [TBL] [Abstract][Full Text] [Related]
16. Thrombocytopenia in extracorporeal circulation (ECC). II: Bubble oxygenator versus artificial kidney. de Jong JC; Smit Sibinga CT; Wildevuur CR Trans Am Soc Artif Intern Organs; 1975; 21():40-8. PubMed ID: 1146013 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of platelet damage in extracorporeal circuits using a visual platelet morphology method. Voorhees CJ; Grover RW; Voorhees ME ASAIO Trans; 1990; 36(3):M664-7. PubMed ID: 2252778 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation. Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411 [TBL] [Abstract][Full Text] [Related]